1. Yang, Qingfan, Gao, Jing, Xu, Lixia, Sung, Joseph J Y, Yu, Jun. 2013. Promoter hypermethylation of BCL6B gene is a potential plasma DNA biomarker for gastric cancer. In Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 18, 721-5. doi:10.3109/1354750X.2013.853839. https://pubmed.ncbi.nlm.nih.gov/24191714/
2. Li, Zhonghao, Wu, Wei, Li, Qiushi, Xiao, Qingzhong, Yan, Yi. 2024. BCL6B-dependent suppression of ETV2 hampers endothelial cell differentiation. In Stem cell research & therapy, 15, 226. doi:10.1186/s13287-024-03832-y. https://pubmed.ncbi.nlm.nih.gov/39075623/
3. Wang, Jia, Dong, Ling, Xu, Lixia, Sung, Joseph J Y, Yu, Jun. 2014. B cell CLL/lymphoma 6 member B inhibits hepatocellular carcinoma metastases in vitro and in mice. In Cancer letters, 355, 192-200. doi:10.1016/j.canlet.2014.08.025. https://pubmed.ncbi.nlm.nih.gov/25218345/
4. Gu, Yue, Li, Aifang, Sun, Hui, Zeng, Zongyue, Zhou, Lan. 2018. BCL6B suppresses proliferation and migration of colorectal carcinoma cells through inhibition of the PI3K/AKT signaling pathway. In International journal of molecular medicine, 41, 2660-2668. doi:10.3892/ijmm.2018.3451. https://pubmed.ncbi.nlm.nih.gov/29393377/
5. Cai, Wang-Yu, Lin, Ling-Yun, Wang, Lin, Chen, Mao-Li, Luo, Qi-Cong. 2019. Inhibition of Bcl6b promotes gastric cancer by amplifying inflammation in mice. In Cell communication and signaling : CCS, 17, 72. doi:10.1186/s12964-019-0387-6. https://pubmed.ncbi.nlm.nih.gov/31288844/
6. Zhang, Runshuai, Ke, Xiaomei, Wu, Kongyue, Zhong, Xueping, Zhao, Haobin. 2018. Expression of the alternative splicing variants of bcl6b in medaka Oryzias latipes. In Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology, 227, 83-89. doi:10.1016/j.cbpb.2018.10.002. https://pubmed.ncbi.nlm.nih.gov/30292753/
7. Li, Xin, Guo, Mingzhou, Yang, Lili, Yu, Jie, Liang, Ping. . BCL6B hypermethylation predicts metastasis and poor prognosis in early-stage hepatocellular carcinoma after thermal ablation. In Journal of cancer research and therapeutics, 17, 644-651. doi:10.4103/jcrt.JCRT_1504_20. https://pubmed.ncbi.nlm.nih.gov/34269294/
8. Yang, Fan, Whelan, Eoin C, Guan, Xuebing, Wu, Xin, Brinster, Ralph L. 2020. FGF9 promotes mouse spermatogonial stem cell proliferation mediated by p38 MAPK signalling. In Cell proliferation, 54, e12933. doi:10.1111/cpr.12933. https://pubmed.ncbi.nlm.nih.gov/33107118/
9. Manders, Peter M, Hunter, Patricia J, Telaranta, Aino I, Ahmed, Rafi, Fearon, Douglas T. 2005. BCL6b mediates the enhanced magnitude of the secondary response of memory CD8+ T lymphocytes. In Proceedings of the National Academy of Sciences of the United States of America, 102, 7418-25. doi:. https://pubmed.ncbi.nlm.nih.gov/15833813/
10. Li, Xin, Yu, Jie, Brock, Malcolm V, Liang, Ping, Guo, Mingzhou. . Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU. In Oncotarget, 6, 11547-60. doi:. https://pubmed.ncbi.nlm.nih.gov/25909168/
智鼠故事 
